Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A
NovoThirteen
Haemophilia A with or without inhibitors. Proposed indication under development: prevention of bleeding and long-term prophylaxis in patients with haemophilia A, irrespective of inhibitor status or severity.
1 trial -
A research study looking at how different doses of study medicine (Inno8) works in the body of healthy men.
NovoThirteen
Prophylaxis and on-demand treatment respectively in patients with haemophilia A with or without FVIII inhibitors.
1 trial -
A research study of how safe a new medicine called NNC0519‑0130 is and to test its effect in people living with excess body weight with or without type 2 diabetes
NovoThirteen
Obesity, Type 2 Diabetes with either overweight or obesity
1 trial -
A single dose, randomized, double-blind 2-arm parallel-group study to compare the pharmacokinetics, immunogenicity, and safety for PB016 versus US-licensed Entyvio® after subcutaneous administration in healthy participants
Lacuna Pharma Pty Ltd
Not applicable, healthy volunteers
1 trial -
A study in healthy men and women to test whether BI 1569912 influences the amount of repaglinide, midazolam and bupropion in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to compare the amount of vicadrostat and empagliflozin in the blood when taken separately and together
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to find out how different doses of BI 3009947 are tolerated and how different formulations or food influence how BI 3009947 is taken up into the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to learn about how the body absorbs, processes, and removes radioactively labeled BAY 3283142
Bayer AG
Chronic kidney disease
1 trial -
A study in healthy men to test how bosentan influences the amount of nerandomilast in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to test how bosentan influences the amount of zongertinib in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to test how different doses of BI 3031185 are tolerated and how food influences the amount of BI 3031185 in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to test how itraconazole influences the amount of BI 764198 in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to test whether BI 1815368 influences the amount of metformin in the body
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to test whether carbamazepine influences the amount of nerandomilast in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to test whether esomeprazole influences the amount of BI 3000202 in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to test whether food influences the amount of BI 3731579 in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to test whether zongertinib influences the amount of 3 other medicines in the blood
Boehringer Ingelheim
Pharmacokinetic trial
1 trial -
A study in healthy men to test whether zongertinib influences the amount of 4 other medicines (dabigatran, rosuvastatin, metformin, and furosemide) in the blood
Boehringer Ingelheim
Pharmacokinetic trial
1 trial -
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy people to test how 2 different formulations of BI 690517 are taken up in the body and how probenecid influences the amount of BI 690517 in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy people to test how BI 1015550 is taken up in the body when given with or without food
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy people to test how itraconazole influences the amount of BI 3031185 in the blood
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy people to test whether BI 1291583 influences the amount of dabigatran in the body
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy people to test whether BI 764198 influences the amount of metformin in the body
Boehringer Ingelheim
Healthy volunteer trial
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources